Contact

Our portfolio

Cellagenics

Cellagenics

Developing STEP® technology, Cellagenics scales up therapeutic antibody production in mammalian cell lines. Their collaboration with Batavia Biosciences aims to enhance biopharmaceutical manufacturing.

  • Institute: University of Amsterdam
Industry: Therapeutics
  • Founding year: 2008
Visit website

Want to get in contact about Cellagenics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

ForceSense
Improving surgical skill development with the Lapron Boxtrainer, a laparoscopic training system.
PacingCure
Developing gene therapy solutions for heart rhythm disorders.
AviSia Therapeutics
Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.
Skyline Dx
Advancing molecular diagnostics for precision oncology and infectious diseases.
ForceSense
Improving surgical skill development with the Lapron Boxtrainer, a laparoscopic training system.
PacingCure
Developing gene therapy solutions for heart rhythm disorders.
AviSia Therapeutics
Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.
Skyline Dx
Advancing molecular diagnostics for precision oncology and infectious diseases.
Explore full AAV portfolio
Contact